HRT FINANCIAL LP

Position in JNJ — Johnson & Johnson

CIK 1475597 NEW YORK, NY

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$262,087,135

+$258,985,162 QoQ

Shares Held

1,031,961

+6784.8% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.72%

of 13F equity value

Holder Rank

#172

of 4,676 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $691,078,789 across 12 Drug Manufacturers - General names. JNJ ranks #1 (37.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	1,031,961	$262,087,135
2	ABBV	AbbVie Inc.	702,907	$176,879,517
3	MRK	Merck & Co., Inc.	798,048	$102,549,168
4	LLY	ELI LILLY & Co	38,616	$46,317,192
5	BMY	Bristol Myers Squibb Co	741,187	$42,707,194
6	GSK	GSK plc	603,902	$31,656,542
7	NVS	Novartis AG	89,587	$14,040,074
8	NVO	Novo Nordisk A S	148,940	$7,140,183

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$262,087,135	1,031,961	+6784.8%	Shares	Defined	2026-08-14
2025-12-31	$3,101,973	14,989	-98.8%	Shares	Defined	2026-02-12
2025-09-30	$222,634,350	1,200,703	+223.7%	Shares	Defined	2025-11-14
2025-06-30	$56,667,958	370,985	+440.2%	Shares	Defined	2025-08-14
2025-03-31	$11,390,057	68,681	-54.4%	Shares	Defined	2025-05-15
2024-12-31	$21,786,858	150,649	-5.1%	Shares	Defined	2025-02-14
2024-09-30	$25,730,914	158,774	+161.8%	Shares	Defined	2024-11-12
2024-06-30	$8,863,580	60,643	-35.3%	Shares	Defined	2024-08-12
2024-03-31	$14,827,939	93,735	-43.2%	Shares	Defined	2024-05-13
2023-06-30	$27,314,938	165,025	+13.6%	Shares	Defined	2023-08-11
2022-09-30	$23,728,366	145,252	+14.1%	Shares	Defined	2022-11-14
2021-06-30	$20,975,520	127,325	+216.4%	Shares	Defined	2021-08-16
2021-03-31	$6,614,101	40,244	-61.1%	Shares	Defined	2021-05-17
2020-06-30	$14,546,204	103,436	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.